Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Leukemia, Experimental D007942 42 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Psoriasis D011565 47 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Thrombosis D013927 49 associated lipids
Osteosarcoma D012516 50 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Liu SH et al. [Effects of p38 mitogen-activated protein kinase in protection of carbon monoxide against lipopolysaccharide induced rat small intestine injury]. 2009 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21189571
Liu J et al. New vernocuminosides from the stem barks of Vernonia cumingiana Benth. 2009 Steroids pmid:18840454
Brooks AC et al. Regulation of platelet activating factor-induced equine platelet activation by intracellular kinases. 2009 J. Vet. Pharmacol. Ther. pmid:19290950
Eckels PC et al. Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils. 2009 Am. J. Physiol., Cell Physiol. pmid:19295175
Melnikova VO and Bar-Eli M Inflammation and melanoma metastasis. 2009 Pigment Cell Melanoma Res pmid:19368690
Sánchez FA et al. Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19342481
Marotta DM et al. Mechanisms underlying the nociceptive responses induced by platelet-activating factor (PAF) in the rat paw. 2009 Biochem. Pharmacol. pmid:19283893
Yost CC et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. 2009 Blood pmid:19221037
Tsoupras AB et al. The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. 2009 Infect Disord Drug Targets pmid:19689381
Cheng L et al. A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:19773578
Mukai K et al. New insights into the roles for basophils in acute and chronic allergy. 2009 Allergol Int pmid:19153532
Eigenmann PA Mechanisms of food allergy. 2009 Pediatr Allergy Immunol pmid:19154253
Knezevic II et al. Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability. 2009 J. Biol. Chem. pmid:19095647
Rigat B et al. GM2 activator protein inhibits platelet activating factor signaling in rats. 2009 Biochem. Biophys. Res. Commun. pmid:19486886
Liu SX et al. Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice. 2009 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19460845
Kovacova E et al. General changes in hemostasis in gastric cancer. 2009 Bratisl Lek Listy pmid:19507648
Sharif NA et al. Human conjunctival epithelial cell responses to platelet-activating factor (PAF): signal transduction and release of proinflammatory cytokines. 2009 Mol. Vis. pmid:19513187
Tang WZ et al. Rearranged prenylated C6-C3 compounds and a highly oxygenated seco-prezizaane-type sesquiterpene from the stem bark of Illicium oligandrum. 2009 J. Nat. Prod. pmid:19496609
Hakim-Rad K et al. Mast cells: makers and breakers of allergic inflammation. 2009 Curr Opin Allergy Clin Immunol pmid:19550301
Li Y et al. Activation of a chloride channel by a trophic ligand is required for development of the mouse preimplantation embryo in vitro. 2009 Biol. Reprod. pmid:19553604
Mayerle J A novel role for leucocytes in determining the severity of acute pancreatitis. 2009 Gut pmid:19834113
Keating FK and Schneider DJ The influence of platelet activating factor on the effects of platelet agonists and antiplatelet agents in vitro. 2009 J. Thromb. Thrombolysis pmid:18574670
Zhang Q et al. Involvement of platelet-activating factor in ultraviolet B-induced hyperalgesia. 2009 J. Invest. Dermatol. pmid:18580961
Babayigit A et al. Effects of Ginkgo biloba on airway histology in a mouse model of chronic asthma. 2009 Mar-Apr Allergy Asthma Proc pmid:19118503
Mrówczyńska L and Hägerstrand H Platelet-activating factor interaction with the human erythrocyte membrane. 2009 Sep-Oct J. Biochem. Mol. Toxicol. pmid:19827129
Chomyszyn-Gajewska M [Evaluation of chosen salivary periodontal disease markers]. 2010 Prz. Lek. pmid:20687387
Thiele T et al. [Heparin-induced thrombocytopenia]. 2010 Internist (Berl) pmid:20694716
Lin S et al. Abietane and C20-norabietane diterpenes from the stem bark of Fraxinus sieboldiana and their biological activities. 2010 J. Nat. Prod. pmid:20961093
He J et al. The induction of an angiogenic response in corneal myofibroblasts by platelet-activating factor (PAF). 2010 Curr. Eye Res. pmid:20961214
de Souza Carmo EV et al. Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages. 2010 PLoS ONE pmid:21082032
Borthakur A et al. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. 2010 Inflamm. Bowel Dis. pmid:19714753
Fité R and Borja J Rupatadine and heart rhythm disturbances. 2010 Clin. Pharmacol. Ther. pmid:19727070
Lorrain DS et al. Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation. 2010 Eur. J. Pharmacol. pmid:20519143
Salmon MD and Ahluwalia J Discrimination between receptor- and store-operated Ca(2+) influx in human neutrophils. 2010 Cell. Immunol. pmid:20716450
Lautenschläger I et al. A model of the isolated perfused rat small intestine. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19910525
Yang Y et al. Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase. 2010 Eur. Respir. J. pmid:19926744
Cureton EL et al. Endothelin 1 and prostacyclin attenuate increases in hydraulic permeability caused by platelet-activating factor in rats. 2010 Shock pmid:19940814
Coppo R et al. Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. 2010 Kidney Int. pmid:20016469
Xu Z et al. Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor. 2010 Mol. Ther. pmid:19953082
Ma J et al. Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19959817
Hasegawa S et al. Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain. 2010 PLoS ONE pmid:20454616
Yang L et al. Chronic alcohol exposure increases circulating bioactive oxidized phospholipids. 2010 J. Biol. Chem. pmid:20460374
Metz M et al. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. 2010 Ann. Allergy Asthma Immunol. pmid:20143651
Xiping Z et al. Effects of dexamethasone and Salvia miltiorrhizae on the small intestine and immune organs of rats with severe acute pancreatitis. 2010 Inflammation pmid:20127399
Incorvaia C et al. Anaphylaxis: an update on its understanding and management. 2010 Recent Pat Inflamm Allergy Drug Discov pmid:20100165
Moriguchi S et al. Platelet-activating factor-induced synaptic facilitation is associated with increased calcium/calmodulin-dependent protein kinase II, protein kinase C and extracellular signal-regulated kinase activities in the rat hippocampal CA1 region. 2010 Neuroscience pmid:20074623
Zhou X and He P Endothelial [Ca2+]i and caveolin-1 antagonistically regulate eNOS activity and microvessel permeability in rat venules. 2010 Cardiovasc. Res. pmid:20080986
Kenchegowda S and Bazan HE Significance of lipid mediators in corneal injury and repair. 2010 J. Lipid Res. pmid:19965607
Jørgensen KM et al. Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2. 2010 Arch. Dermatol. Res. pmid:20041255
Coy Barrera ED and Cuca Suárez LE In vitro inhibitory activities of Lauraceae aporphine alkaloids. 2010 Nat Prod Commun pmid:20420312